Newsfeeds - Spark Newswire

9 minute read

Puma Biotechnology Presents Updates From SUMMIT Trial At 2021 SABCS Annual Meeting

Today, 6:15 AM

Puma Biotechnology, Inc. (NASDAQ:PBYI), a biopharmaceutical company, presented an update from its Phase II SUMMIT trial at the ongoing 2021 San Antonio Breast Cancer Symposium (SABCS) Annual Meeting. The data presented

PBYI

4 minute read

The Daily Biotech Pulse: Lilly Sings Metabolic Disorder Drug Pact, Moderna Reports Positive Flu Vaccine Data, Halozyme To Buy Back Shares

By Shanthi Rexaline

Today, 6:15 AM

Here's a roundup of top developments in the biotech space over the last 24 hours.

ABBV

1 minute read

Puma Biotech’s Neratinib Fails To Extend Overall Survival In Brain Cancer Trial

By Vandana Singh

Today, 6:15 AM

Puma Biotechnology Inc (NASDAQ:PBYI) announced interim data from the neratinib arm of Phase 2 INSIGhT Trial in newly diagnosed unmethylated glioblastoma…

PBYI

3 minute read

Puma Biotechnology Announced Data from the Neratinib Arm of the INSIGhT Trial at the 2021 SNO Annual Meeting; Said Preliminary Results Did Not Achieve Primary Endpoint

By Charles Gross

Today, 6:15 AM

Puma Biotechnology, Inc. (Nasdaq: PBYI), a biopharmaceutical company, announced that investigators presented results from the neratinib arm of the Phase II Individualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT Trial) at the 2021 Society for Neuro-Oncology Annual Meeting.

PBYI

7 minute read

92 Biggest Movers From Friday

By Lisa Levin

Today, 6:15 AM

Gainers

AAOI

5 minute read

64 Stocks Moving In Friday’s Mid-Day Session

By Lisa Levin

Today, 6:15 AM

Gainers Mainz Biomed B.V. (NASDAQ: MYNZ) shares climbed 198.4% to $14.92. Mainz Biomed priced its initial public offering of 2 million ordinary shares at $5, the middle of the estimated price range of $4-$6, for raising gross proceeds of $10 million.

AAOI

4 minute read

The Daily Biotech Pulse: NRx’s Zyesami Face Regulatory Rejection, Puma Slumps On Q3 Miss, Pfizer Has Good Tidings On Oral Antiviral COVID-19 Pill

By Shanthi Rexaline

Today, 6:15 AM

Here's a roundup of top developments in the biotech space over the last 24 hours.

ACXP

32 minute read

Earnings Scheduled For November 4, 2021

By Benzinga Insights

Today, 6:15 AM

Companies Reporting Before The Bell • DISH Network (NASDAQ:DISH) is likely to report quarterly earnings at $0.91 per share on revenue of $4.45 billion.

AAOI

7 minute read

The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline

By Shanthi Rexaline

Today, 6:15 AM

Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected.

ADPT

2 minute read

Celcuity Announces Clinical Trial Collaboration With University Of Rochester Wilmot Cancer Center And Puma Biotechnology To Conduct Phase 2 Trial Of NERLYNX Plus XELODA

By Bill Haddad

Today, 6:15 AM

have metastatic HER2-negative breast cancer with brain metastases The unique tumor insights CELsignia generates enable identification of new potential applications for targeted therapies and development of potential

CELC